Zortress
Showing 1 - 25 of 74
Renal Failure Trial in Columbus (Everolimus, Sirolimus)
Completed
- Renal Failure
-
Columbus, OhioThe Ohio State University Wexner Medical Center
Nov 2, 2021
Idiopathic Subglottic Tracheal Stenosis Trial in Baltimore (Everolimus Oral Tablet)
Recruiting
- Idiopathic Subglottic Tracheal Stenosis
- Everolimus Oral Tablet
-
Baltimore, MarylandJohns Hopkins Outpatient Center
Jul 28, 2022
Liver Transplant Trial in Boston (biological, procedure, drug)
Recruiting
- Liver Transplant
- arTreg-CSB
- +4 more
-
Boston, MassachusettsMassachusetts General Hospital: Transplantation
Jan 30, 2023
Cutaneous Squamous Cell Carcinoma, Advanced Cancer Trial in Boston (Cemiplimab, Everolimus, Sirolimus)
Recruiting
- Cutaneous Squamous Cell Carcinoma
- Advanced Cancer
- Cemiplimab
- +3 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 19, 2023
Gastrointestinal Stromal Tumor Trial (Everolimus)
Temporarily not available
- Gastrointestinal Stromal Tumor
- (no location specified)
May 5, 2022
Renal Transplant Trial in Toledo (Arm 1 Everolimus/Reduced dose tacrolimus)
Completed
- Renal Transplant
- Arm 1 Everolimus/Reduced dose tacrolimus
-
Toledo, OhioUniversity of Toledo, Health Science Campus
May 2, 2022
Liver Transplant Trial in San Francisco (biological, procedure, drug)
Recruiting
- Liver Transplant
- arTreg
- +4 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 13, 2022
Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Everolimus, Laboratory
Recruiting
- Advanced Malignant Neoplasm
- +3 more
- Everolimus
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 9, 2022
Liver Transplantation Trial in Chicago (Tacrolimus Withdrawal and Everolimus Monotherapy)
Completed
- Liver Transplantation
- Tacrolimus Withdrawal and Everolimus Monotherapy
-
Chicago, IllinoisNorthwestern University Comprehensive Transplant Center
Apr 6, 2021
Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston
Recruiting
- Advanced Carcinoid Tumor
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Metastatic Midgut Neuroendocrine Tumor, Unresectable Midgut Neuroendocrine Tumor Trial (procedure, drug, other)
Not yet recruiting
- Metastatic Midgut Neuroendocrine Tumor
- Unresectable Midgut Neuroendocrine Tumor
- Biospecimen Collection
- +5 more
- (no location specified)
Mar 16, 2023
Delayed Graft Function Trial in Columbus (Belatacept, Everolimus)
Terminated
- Delayed Graft Function
-
Columbus, OhioThe Ohio State Universtiy Wexner Medical Center
Sep 17, 2021
Carcinoma, Hepatocellular Trial in United States (Everolimus, Tacrolimus, Myfortic)
Active, not recruiting
- Carcinoma, Hepatocellular
- Everolimus
- +4 more
-
San Francisco, California
- +8 more
Jul 19, 2022
Kidney Transplant Rejection, Gastrointestinal Disorder, Functional Trial in Saint Louis (Everolimus, Mycophenolic Acid)
Terminated
- Kidney Transplant Rejection
- Gastrointestinal Disorder, Functional
- Everolimus
- Mycophenolic Acid
-
Saint Louis, MissouriWashington University
Aug 7, 2020
Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial
Recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +3 more
- Cabozantinib
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 17, 2022
Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant Trial in United States (biological, drug,
Recruiting
- Kidney Transplant
- +3 more
- Polyclonal Regulatory T Cells
- +10 more
-
Birmingham, Alabama
- +5 more
Feb 22, 2022
Advanced Lung Carcinoid Tumor, Functioning Lung Carcinoid Tumor, Locally Advanced Lung Neuroendocrine Tumor Trial in Boston,
Recruiting
- Advanced Lung Carcinoid Tumor
- +11 more
- Everolimus
- Lutetium Lu 177 Dotatate
-
Boston, Massachusetts
- +1 more
Jul 19, 2022
Recurrent Endometrial Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Carcinoma Trial in
Recruiting
- Recurrent Endometrial Carcinoma
- +12 more
- Everolimus
- +2 more
-
Houston, Texas
- +1 more
Sep 22, 2022
Adenocarcinoma, Pancreatic Tumors Trial in Saint Louis, Nashville (X-82, Everolimus)
Terminated
- Adenocarcinoma
- Pancreatic Neoplasms
-
Saint Louis, Missouri
- +1 more
Jun 15, 2021
Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,
Recruiting
- Advanced Malignant Solid Neoplasm
- +9 more
- Everolimus
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 25, 2022
Recurrent World Health Organization (WHO) Grade II Glioma Trial in United States (Everolimus, Trametinib)
Recruiting
- Recurrent World Health Organization (WHO) Grade II Glioma
-
Birmingham, Alabama
- +11 more
May 6, 2022